Hochheim, Germany

Hans-Ludwig Schäfer

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
7 patents (USPTO):

Title: The Innovations of Hans-Ludwig Schäfer

Introduction

Hans-Ludwig Schäfer is a notable inventor based in Hochheim, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on diphenylazetidinones. With a total of seven patents to his name, Schäfer has established himself as a key figure in the development of new pharmaceutical compounds.

Latest Patents

Among his latest patents, Schäfer has focused on diphenylazetidinones, detailing processes for their preparation and the medicaments that comprise these compounds. These compounds, represented by a specific formula, are designed for use as hypolipidemics, which are medications that help lower lipid levels in the blood. The physiologically acceptable salts of these compounds further enhance their therapeutic potential.

Career Highlights

Throughout his career, Hans-Ludwig Schäfer has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH. His work in these organizations has allowed him to collaborate on various innovative projects that have advanced the field of medicine.

Collaborations

Schäfer has collaborated with several notable colleagues, including Heiner Glombik and Wendelin Frick. These partnerships have contributed to the successful development of his patented compounds and have fostered a collaborative environment for innovation.

Conclusion

Hans-Ludwig Schäfer's contributions to medicinal chemistry through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to impact the development of new treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…